Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,614 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01395758 | Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 96 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 3, 2018 | clinicaltrials |
| NCT00729612 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 63 | Greg Otterson |
| 1 |
| Apr 2, 2018 |
| clinicaltrials |
| NCT01752400 | AUY922 for Advanced ALK-positive NSCLC | completed | Phase 2 | 6 | Massachusetts General HospitalOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT00923312 | Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 46 | CureVacINDUSTRY | 2 | Mar 20, 2018 | clinicaltrials |
| NCT02090660 | Technique for Localization of Pulmonary Nodules Using Spy Thoracoscope System | completed | Phase 2 | 20 | University Health Network, TorontoOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT00462995 | Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)(SELECT) | completed | Phase 2 | 25 | University Health Network, TorontoOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT00997334 | Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC | completed | Phase 2 | 60 | David M. Jackman, MDOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT00399789 | A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 121 | AEterna ZentarisINDUSTRY | 1 | Feb 22, 2018 | clinicaltrials |
| NCT02146092 | Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery | completed | Phase 2 | 389 | McMaster UniversityOTHER | 1 | Feb 14, 2018 | clinicaltrials |
| NCT00072631 | Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 43 | OSI PharmaceuticalsINDUSTRY | 1 | Feb 8, 2018 | clinicaltrials |
| NCT00553462 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 78 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT00138203 | Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | Jan 30, 2018 | clinicaltrials |
| NCT01378962 | A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER) | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00387660 | Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer | completed | Phase 2 | 80 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00577707 | Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) | completed | Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT01676714 | Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer | completed | Phase 2 | 10 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00365547 | Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy | completed | Phase 2 | 46 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer | completed | Phase 2 | 38 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT02182050 | Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer | completed | Phase 2 | 73 | Boehringer IngelheimINDUSTRY | 0 | Dec 28, 2017 | clinicaltrials |
| NCT00230126 | OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer | completed | Phase 2 | 57 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 26, 2017 | clinicaltrials |
| NCT00023673 | Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 63 | Radiation Therapy Oncology GroupNETWORK | 2 | Dec 22, 2017 | clinicaltrials |
| NCT00066222 | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 72 | Radiation Therapy Oncology GroupNETWORK | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03371550 | A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy(TAXCIS) | completed | Phase 2 | 44 | Centre Antoine LacassagneOTHER | 0 | Dec 13, 2017 | clinicaltrials |
| NCT00093756 | Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Dec 7, 2017 | clinicaltrials |
| NCT00528645 | AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | Dec 7, 2017 | clinicaltrials |
| NCT00362882 | Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 81 | National Cancer Institute (NCI)NIH | 1 | Dec 5, 2017 | clinicaltrials |
| NCT00783705 | Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | completed | Phase 2 | 85 | National Cancer Institute (NCI)NIH | 2 | Dec 5, 2017 | clinicaltrials |
| NCT01648517 | Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy | completed | Phase 2 | 60 | Yonsei UniversityOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT01344824 | Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers | completed | Phase 2 | 38 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT00374140 | Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer | completed | Phase 2 | 40 | Ahmad TarhiniOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT02388919 | Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）(ALTER0303) | completed | Phase 2 / Phase 3 | 439 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Sep 18, 2017 | clinicaltrials |
| NCT00985855 | Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 91 | Institut de Cancérologie de la LoireOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT01217619 | Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.(ML25444) | completed | Phase 2 | 25 | Baohui HanOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT01262560 | Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer | completed | Phase 2 | 163 | Radiation Therapy Oncology GroupNETWORK | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01987232 | Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | AmgenINDUSTRY | 3 | Aug 28, 2017 | clinicaltrials |
| NCT00452244 | Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 110 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 25, 2017 | clinicaltrials |
| NCT01441297 | BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer | completed | Phase 2 | 24 | Ji-youn HanOTHER_GOV | 1 | Aug 25, 2017 | clinicaltrials |
| NCT00828139 | S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 189 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00531284 | Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma | completed | Phase 1 / Phase 2 | 184 | AmgenINDUSTRY | 1 | Aug 15, 2017 | clinicaltrials |
| NCT00410059 | BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC | completed | Phase 2 | 59 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT01858389 | A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 41 | PfizerINDUSTRY | 2 | Jul 18, 2017 | clinicaltrials |
| NCT00655850 | Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 39 | University of Alabama at BirminghamOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00856830 | Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 30 | University of Alabama at BirminghamOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | completed | Phase 1 / Phase 2 | 73 | Zhejiang Cancer HospitalOTHER | 1 | Jul 14, 2017 | clinicaltrials |
| NCT00248495 | Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 38 | Roswell Park Cancer InstituteOTHER | 1 | Jul 12, 2017 | clinicaltrials |
| NCT00280735 | Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC | completed | Phase 2 | 75 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01909752 | Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer | completed | Phase 2 | 12 | UbiVacINDUSTRY | 1 | Jul 6, 2017 | clinicaltrials |
| NCT01807546 | Oral Rigosertib for Squamous Cell Carcinoma | completed | Phase 2 | 64 | Traws Pharma, Inc.INDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT01233687 | AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 49 | Ahmad TarhiniOTHER | 1 | Jun 22, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Apr 3, 2018source: clinicaltrials